InsiderSource
ROIV

Roivant Sciences Ltd.

SEC CIK 1635088
$30.03 +42.1% · 90 days
90-day buys
$0
0 open-market
90-day sells
$22.73M
5 open-market
Net insider flow
−$22.73M
Net selling
Filings shown
54
Most recent
Advertisement

At a glance

Over the last 90 days, insiders at ROIV have sold a net $22.73M of stock (0 open-market buys vs 5 sells).

Largest recent trade: Torti Frank sold $38.39M of ROIV, trimming their stake 9%.

Most active filer: Venker Eric, with 10 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for ROIV, newest first
View on SEC EDGAR ↗
ROIV
Roivant Sciences Ltd.
Sell Torti Frank · President and Vant Chair · Open-market sale · filed Feb 23, 2026 ΔOwn −4.1%

Torti Frank sold $16.16M of ROIV, trimming their stake 4%.

−$16.16M
587,390 sh @ $28
ROIV
Roivant Sciences Ltd.
Tax withholding Venker Eric · President & Immunovant CEO · Tax withholding · filed Feb 24, 2026 ΔOwn −0.4%
−$191.4K
7,051 sh @ $27
ROIV
Roivant Sciences Ltd.
Sell Torti Frank · President and Vant Chair · Open-market sale · filed Feb 23, 2026 ΔOwn −6.9%

Torti Frank sold $27.49M of ROIV, trimming their stake 7%.

−$27.49M
1.01M sh @ $27
Advertisement
ROIV
Roivant Sciences Ltd.
Sell Torti Frank · President and Vant Chair · Open-market sale · filed Feb 23, 2026 ΔOwn −9.2%

Torti Frank sold $38.39M of ROIV, trimming their stake 9%.

−$38.39M
1.4M sh @ $27
ROIV
Roivant Sciences Ltd.
Option exercise Venker Eric · President & Immunovant CEO · Option exercise · filed Feb 18, 2026 ΔOwn +12%
+$770K
200,000 sh @ $4
ROIV
Roivant Sciences Ltd.
Sell Venker Eric · President & Immunovant CEO · Open-market sale · filed Feb 18, 2026 ΔOwn −11%

Venker Eric sold $5.3M of ROIV, trimming their stake 11%.

−$5.3M
200,000 sh @ $26
ROIV
Roivant Sciences Ltd.
Sell MANCHESTER KEITH S · Director · Open-market sale · filed Feb 13, 2026 ΔOwn −1.0%

Manchester Keith S sold $3.99M of ROIV, trimming their stake 1%.

−$3.99M
150,784 sh @ $26
ROIV
Roivant Sciences Ltd.
Sell MANCHESTER KEITH S · Director · Open-market sale · filed Feb 13, 2026 ΔOwn −1.5%

Manchester Keith S sold $5.96M of ROIV, trimming their stake 1%.

−$5.96M
225,000 sh @ $27
ROIV
Roivant Sciences Ltd.
Sell Gold Daniel Allen · Director · Open-market sale · filed Feb 13, 2026 ΔOwn −1.0%

Gold Daniel Allen sold $3.99M of ROIV, trimming their stake 1%.

−$3.99M
150,784 sh @ $26
ROIV
Roivant Sciences Ltd.
Sell Gold Daniel Allen · Director · Open-market sale · filed Feb 13, 2026 ΔOwn −1.5%

Gold Daniel Allen sold $5.96M of ROIV, trimming their stake 1%.

−$5.96M
225,000 sh @ $27
ROIV
Roivant Sciences Ltd.
Sell QVT Financial LP · Insider · Open-market sale · filed Feb 13, 2026 ΔOwn −1.0%

Qvt Financial Lp sold $3.99M of ROIV, trimming their stake 1%.

−$3.99M
150,784 sh @ $26
ROIV
Roivant Sciences Ltd.
Sell QVT Financial LP · Insider · Open-market sale · filed Feb 13, 2026 ΔOwn −1.5%

Qvt Financial Lp sold $5.96M of ROIV, trimming their stake 1%.

−$5.96M
225,000 sh @ $27
ROIV
Roivant Sciences Ltd.
Sell MANCHESTER KEITH S · Director · Open-market sale · filed Feb 13, 2026 ΔOwn −0.9%

Manchester Keith S sold $4.01M of ROIV, trimming their stake 1%.

−$4.01M
150,000 sh @ $27
ROIV
Roivant Sciences Ltd.
Sell MANCHESTER KEITH S · Director · Open-market sale · filed Feb 13, 2026 ΔOwn −1.7%

Manchester Keith S sold $7.36M of ROIV, trimming their stake 2%.

−$7.36M
275,000 sh @ $27
ROIV
Roivant Sciences Ltd.
Sell Gold Daniel Allen · Director · Open-market sale · filed Feb 13, 2026 ΔOwn −0.9%

Gold Daniel Allen sold $4.01M of ROIV, trimming their stake 1%.

−$4.01M
150,000 sh @ $27
ROIV
Roivant Sciences Ltd.
Sell Gold Daniel Allen · Director · Open-market sale · filed Feb 13, 2026 ΔOwn −1.7%

Gold Daniel Allen sold $7.36M of ROIV, trimming their stake 2%.

−$7.36M
275,000 sh @ $27
ROIV
Roivant Sciences Ltd.
Sell QVT Financial LP · Insider · Open-market sale · filed Feb 13, 2026 ΔOwn −0.9%

Qvt Financial Lp sold $4.01M of ROIV, trimming their stake 1%.

−$4.01M
150,000 sh @ $27
ROIV
Roivant Sciences Ltd.
Sell QVT Financial LP · Insider · Open-market sale · filed Feb 13, 2026 ΔOwn −1.7%

Qvt Financial Lp sold $7.36M of ROIV, trimming their stake 2%.

−$7.36M
275,000 sh @ $27
ROIV
Roivant Sciences Ltd.
Sell MANCHESTER KEITH S · Director · Open-market sale · filed Feb 13, 2026 ΔOwn −2.6%

Manchester Keith S sold $11.33M of ROIV, trimming their stake 3%.

−$11.33M
425,000 sh @ $27
ROIV
Roivant Sciences Ltd.
Sell Gold Daniel Allen · Director · Open-market sale · filed Feb 13, 2026 ΔOwn −2.6%

Gold Daniel Allen sold $11.33M of ROIV, trimming their stake 3%.

−$11.33M
425,000 sh @ $27
ROIV
Roivant Sciences Ltd.
Sell QVT Financial LP · Insider · Open-market sale · filed Feb 13, 2026 ΔOwn −2.6%

Qvt Financial Lp sold $11.33M of ROIV, trimming their stake 3%.

−$11.33M
425,000 sh @ $27
Advertisement

About ROIV insider activity

This page tracks every recent Form 4 filed for Roivant Sciences Ltd. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is ROIV insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for Roivant Sciences Ltd. usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.